Medicare Enrolled
Dr. Daniel Huang, M.D.
Internal Medicine · Santa Ana, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Huang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Huang
Dr. Daniel Huang is an internal medicine specialist in Santa Ana, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Huang performed 4,199 Medicare services across 637 unique beneficiaries.
Between the years covered by Open Payments, Dr. Huang received a total of $36,483 from 111 pharmaceutical and/or device companies across 1744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Huang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$36,483 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,199
Medicare services
Top 7% in CA for internal medicine
637
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~221 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,530 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 1,008 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
421 | $104 | $268 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
138 | $65 | $192 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
134 | $117 | $291 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
114 | $25 | $64 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
110 | $8 | $14 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
100 | $1 | $2 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
90 | $85 | $140 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
83 | $25 | $61 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
58 | $24 | $60 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
58 | $65 | $167 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
50 | $67 | $152 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
48 | $12 | $31 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
46 | $56 | $146 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
42 | $56 | $139 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
41 | $14 | $32 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $108 | $274 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $126 | $341 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
28 | $52 | $193 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
21 | $4 | $11 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
14 | $69 | $162 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.0% high complexity
68.3% medium
23.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$36,483
Total received (2018-2024)
Avg $5,212/year across 7 years
Top 4% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
111
Companies
1,744
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,386 (91.5%)
Other
Charitable contributions, space rental, and other categories
$1,346 (3.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,320 (3.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$430 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,419
2023
$6,284
2022
$6,332
2021
$4,855
2020
$5,363
2019
$3,341
2018
$2,889
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,346
Janssen Biotech, Inc.
$543
Takeda Pharmaceuticals U.S.A., Inc.
$370
AstraZeneca Pharmaceuticals LP
$370
E.R. Squibb & Sons, L.L.C.
$303
GlaxoSmithKline, LLC.
$291
PFIZER INC.
$288
Eisai Inc.
$262
Lilly USA, LLC
$230
Astellas Pharma US Inc
$211
Merck Sharp & Dohme LLC
$171
Bayer Healthcare Pharmaceuticals Inc.
$158
SOBI, INC
$158
Alexion Pharmaceuticals, Inc.
$154
Incyte Corporation
$147
PUMA BIOTECHNOLOGY, INC.
$144
Karyopharm Therapeutics Inc.
$140
Boehringer Ingelheim Pharmaceuticals, Inc.
$134
ABBVIE INC.
$134
EMD Serono, Inc.
$115
Genentech USA, Inc.
$114
BeiGene USA, Inc.
$114
Regeneron Healthcare Solutions, Inc.
$113
Daiichi Sankyo Inc.
$95
SEAGEN INC.
$95
ARRAY BIOPHARMA INC
$93
Exelixis Inc.
$70
ADC Therapeutics America, Inc.
$69
SpringWorks Therapeutics, Inc.
$66
Gilead Sciences, Inc.
$66
Agios Pharmaceuticals, Inc.
$64
Celgene Corporation
$62
TAIHO ONCOLOGY, INC.
$56
Blueprint Medicines Corporation
$56
Coherus Biosciences Inc.
$54
PharmaEssentia USA Corporation
$54
GENZYME CORPORATION
$54
Kite Pharma, Inc.
$54
PROGENICS PHARMACEUTICALS, INC.
$48
Rigel Pharmaceuticals, Inc.
$44
Stemline Therapeutics Inc.
$43
Sumitomo Pharma America, Inc.
$38
Apellis Pharmaceuticals, Inc.
$34
Legend Biotech USA Inc.
$28
Deciphera Pharmaceuticals Inc.
$27
Kyowa Kirin, Inc.
$25
Secura Bio, Inc.
$23
MorphoSys, US Inc.
$22
Mirati Therapeutics, Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Aveo Pharmaceuticals, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$16
Top 3 companies account for 30.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,585
Janssen Biotech, Inc.
$2,090
E.R. Squibb & Sons, L.L.C.
$2,044
Incyte Corporation
$1,661
AstraZeneca Pharmaceuticals LP
$1,576
Verastem, Inc.
$1,433
PFIZER INC.
$1,343
Celgene Corporation
$1,222
Eisai Inc.
$1,167
Amgen Inc.
$1,004
Astellas Pharma US Inc
$877
Lilly USA, LLC
$873
GlaxoSmithKline, LLC.
$873
Pharmacyclics LLC, An AbbVie Company
$844
Takeda Pharmaceuticals U.S.A., Inc.
$773
Merck Sharp & Dohme Corporation
$615
Boehringer Ingelheim Pharmaceuticals, Inc.
$593
Regeneron Healthcare Solutions, Inc.
$576
Genentech USA, Inc.
$561
Karyopharm Therapeutics Inc.
$527
Alexion Pharmaceuticals, Inc.
$505
Puma Biotechnology, Inc.
$480
Bayer HealthCare Pharmaceuticals Inc.
$474
Seagen Inc.
$468
Merck Sharp & Dohme LLC
$452
EMD Serono, Inc.
$422
BeiGene USA, Inc.
$419
Daiichi Sankyo Inc.
$415
Gilead Sciences, Inc.
$415
Exelixis Inc.
$407
ARRAY BIOPHARMA INC
$386
CSL Behring
$351
GENZYME CORPORATION
$336
Kite Pharma, Inc.
$333
Bayer Healthcare Pharmaceuticals Inc.
$305
EISAI INC.
$293
Dendreon Pharmaceuticals LLC
$263
Rigel Pharmaceuticals, Inc.
$240
SOBI, INC
$235
PUMA BIOTECHNOLOGY, INC.
$228
ABBVIE INC.
$220
Myovant Sciences Inc.
$213
Pharmacyclics LLC, an AbbVie Company
$188
Sumitomo Pharma America, Inc.
$176
Blueprint Medicines Corporation
$175
Clovis Oncology, Inc.
$151
Ipsen Biopharmaceuticals, Inc
$140
AbbVie Inc.
$131
Agios Pharmaceuticals, Inc.
$127
PharmaEssentia USA Corporation
$124
EUSA Pharma (US) LLC
$120
Octapharma USA, Inc.
$117
MorphoSys, US Inc.
$115
Stryker Corporation
$111
AVEO Pharmaceuticals, Inc.
$110
CTI BioPharma Corp.
$105
Kyowa Kirin, Inc.
$97
SEAGEN INC.
$95
Foundation Medicine, Inc.
$91
ADC Therapeutics America, Inc.
$91
Global Blood Therapeutics, Inc.
$83
Stemline Therapeutics Inc.
$79
Janssen Scientific Affairs, LLC
$77
Taiho Oncology, Inc.
$76
Mirati Therapeutics, Inc.
$73
Epizyme, Inc.,
$70
ImmunoGen, Inc.
$70
Seattle Genetics, Inc.
$67
SpringWorks Therapeutics, Inc.
$66
Emmaus Medical, Inc.
$63
Apellis Pharmaceuticals, Inc.
$61
Array BioPharma Inc.
$60
SANOFI-AVENTIS U.S. LLC
$57
TESARO, Inc.
$56
TAIHO ONCOLOGY, INC.
$56
Sobi, Inc
$56
Coherus Biosciences Inc.
$54
TOLMAR Pharmaceuticals, Inc.
$53
Adaptive Biotechnologies Corporation
$52
Secura Bio, Inc.
$50
Teva Pharmaceuticals USA, Inc.
$50
PROGENICS PHARMACEUTICALS, INC.
$48
Deciphera Pharmaceuticals Inc.
$41
AMAG Pharmaceuticals, Inc.
$41
Aveo Pharmaceuticals, Inc.
$41
Novocure Inc.
$39
INSYS Therapeutics Inc
$38
Dova Pharmaceuticals
$36
Partner Therapeutics, Inc.
$35
RECORDATI_RARE_DISEASES_INC.
$33
Legend Biotech USA Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
Aurobindo Pharma USA, Inc.
$28
Myriad Genetic Laboratories, Inc.
$26
Sun Pharmaceutical Industries Inc.
$26
Acrotech Biopharma LLC
$25
Mylan Institutional Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Otsuka America Pharmaceutical, Inc.
$24
AbbVie, Inc.
$22
Shire North American Group Inc
$22
Helsinn Therapeutics (U.S.), Inc.
$20
GE HEALTHCARE
$19
ACCORD HEALTHCARE, INC.
$19
Heron Therapeutics, Inc.
$17
Chiesi USA, Inc.
$17
MEDIVATION FIELD SOLUTIONS LLC
$17
Janssen Pharmaceuticals, Inc
$15
Optos, Inc.
$14
Cumberland Pharmaceuticals, Inc.
$14
Sirtex Medical Inc
$11
Top 3 companies account for 21.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CINVANTI · COPIKTRA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Endari · Enhertu · Erleada · FERAHEME · FERRIPROX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAMIFANT · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · GRANIX · HEMADY · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · N/A · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · ODOMZO · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PANORAMIC OPHTHALMOSCOPE · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VALCHLOR · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
2,540
Per 100K population
80.3
County median income
$113,702
Nearest hospital
ORANGE COUNTY GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Huang is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Huang experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Huang performed 1,530 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huang receive payments from pharmaceutical companies?
Yes. Dr. Huang received a total of $36,483 from 111 companies across 1,744 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huang's costs compare to other internal medicine physicians in Santa Ana?
Dr. Huang's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Santa Ana
Browse internal medicine physicians in Santa Ana ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology